BioPortfolio Specialist Market Reports

Biotechnology, Life Science Healthcare and Pharmaceutical Market Research and Corporate Data

BioPortfolio

Search Results for "Cancer Disease" Market Reports

Search our comprehensive collection of reports on Markets and Businesses.
Buy reports at huge discounts from leading Market Research companies with deep and extensive industry knowledge.

Use the search box below to find reports.

search keyword:
price:
published:
region:
search now...

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) - Global Forecast to 2024 [Published by MarketsandMarkets]

“High incidence of cancer & other target diseases, availability of reimbursement, and the growing focus on personalized medicine are driving the overall growth of the anatomic pathology market”The anatomic pathology market is projected to reach a value of USD 44.4 billion by 2024 from USD 33.0 billion in 2019, at a CAGR of 6.1% during the forecast period. The growth in this market is attribute...Read More >>>

Published:
2019-10-30

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024 [Published by MarketsandMarkets]

“The lymphedema diagnostics market is projected to grow at a CAGR of 7.4% during the forecast period.”The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%. The major factors driving the growth of this market include the increasing global prevalence of cancer and lymphedema; technological advancements in diagnostic ...Read More >>>

Published:
2019-10-25

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Human Microbiome Market by Product (Prebiotic, Probiotic, Food, Medical Food, Drug), Application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological), Research Technology (Proteomics, Metabolomics) - Global Forecast to 2027 [Published by MarketsandMarkets]

“Increased focus on human microbiome therapy development to drive the growth of this market.”The global human microbiome market is projected to reach USD 1,731 million in 2027 from 942 million in 2024, at CAGR of 22.5 % during the forecast period. Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for dr...Read More >>>

Published:
2019-09-03

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Global Cancer/Tumor Profiling Market Size study, by Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry and other technologies) Cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer and other cancer) Applications (Clinical Application and Research Applications) and Regional Forecasts 2019-2026. [Report Updated: 10-07-2019]

Global Cancer/Tumor Profiling Market is valued approximately USD 5.9 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.7 % over the forecast period 2019-2026. Growing focus for the development of personalized medicine, growing utility of biomarkers in tumor profiling and increasing R&D investments in cancer are some major trends that are responsible for the wide...Read More >>>

Published:
2019-07-10

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Global Cancer or Tumor Profiling Market Size study, By Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry, other technologies), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer, other cancer), By Applications (Clinical Application, Research Applications) and Regional Forecasts 2019-2026. [Report Updated: 10-07-2019]

Global Cancer or Tumor Profiling Market is valued approximately USD 5.87 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.74% over the forecast period 2019-2026. Growing focus for the development of personalized medicine, growing utility of biomarkers in tumor profiling and increasing R&D investments in cancer are some major trends that are responsible for the ...Read More >>>

Published:
2019-07-10

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Global Radiotherapy Market Size study, by Type (External beam radiation therapy, Internal radiation therapy and Systemic radiation therapy), Application (skin & lip cancer, breast Cancer, head & neck cancer, prostate cancer, cervical cancer, spine cancer, lung cancer and others) End-user (hospitals, cancer research institutes and ambulatory & radiotherapy centers) and Regional Forecasts 2018-2025 [Report Updated: 08-02-2019]

Global Radiotherapy Market to reach USD 12.3 billion by 2025.Global radiotherapy market is valued at approximately USD 7.2 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 6.90 % over the forecast period 2018-2025. Technological advancements in radiotherapy and increasing government investments to meet the demand for cancer treatment are some key trend triggering ...Read More >>>

Published:
2019-02-08

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Published:
2018-12-21

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Global Oncolytic Virus Therapy Market Size study, by Type (Oncolytic Wild Type Viruses, Genetically Engineered Oncolytic Viruses), by Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer) and Regional Forecasts 2018-2025 [Report Updated: 01-12-2018]

Global Oncolytic Virus Therapy Market to reach USD XX million by 2025.Global Oncolytic Virus Therapy Market valued approximately USD XX million in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Oncolytic Virus Therapy Market is continuously growing across the world over the coming years. The major driving factor of global oncolytic v...Read More >>>

Published:
2018-12-01

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Global Blood Brain Barrier Technologies Market Size study, by Disease Type(Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunters Syndrome, Brain Cancer), by Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Rising Permeability of BBB, Passive Diffusion, Other Non-Invasive BBB Technologies), by and Regional Forecasts 2018-2025 [Report Updated: 21-11-2018]

Global Blood Brain Barrier Technologies Market to reach USD xxx billion by 2025.Global Blood Brain Barrier Technologies Market valued approximately USD xxx billion in 2017 is anticipated to grow with a healthy growth rate of more than xxx% over the forecast period 2018-2025. The Blood Brain Barrier Technologies market is developing and expanding at a significant pace. The Blood Brain barrier is pr...Read More >>>

Published:
2018-11-21

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Global Biomarker technologies Market Size study, by Product (Consumables, Service), by Type (Safety, Efficacy, Validation), by Disease Indication (Cancer, Cardiovascular Disorders), by Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk) and by Regional Forecasts 2017-2025. [Report Updated: 04-06-2018]

Global Biomarker technologies Market to reach USD 96.8 billion by 2025.Global Biomarker technologies Market valued approximately USD 42.8 billion in 2016 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2017-2025. Key factors which give growth to the Biomarker technologies market are increasing diagnostic applications of biomarkers, increasing R&D fundin...Read More >>>

Published:
2018-06-04

Published by: Bizwit Research and Consulting

Prices Starting From:
$3358

save $593 today

Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Kit, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User - Global Forecast to 2023 [Report Updated: 28-02-2018]

“The global immunofluorescence assay market projected to grow at a CAGR of 5.8%.”The immunofluorescence assay market is expected to reach USD 2.01 billion by 2023 from an estimated USD 1.51 billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare expenditure are the major factors driving the growth of the significant ...Read More >>>

Published:
2018-02-28

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Engineered T Cells Market by Type (Tumor Infiltrating Lymphocytes, T Cell Receptor, and Chimeric Antigen Receptor), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Leukemia, and Others), and End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023 [Report Updated: 01-01-2018]

T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient’s body to reduce toxicity levels and restrict antigen escape (inability of immune system to respon...Read More >>>

Published:
2018-01-01

Published by: Allied Market Research

Prices Starting From:
$3264

save $576 today

Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022 [Report Updated: 07-12-2017]

“The gastrointestinal stents market is projected to grow at a CAGR of 5.1% between 2017 and 2022.”The gastrointestinal stents market is expected to reach USD 452.6 million by 2022 from USD 353.4 million in 2017, at a CAGR of 5.1% from 2017 to 2022. The rising prevalence of gastrointestinal cancers and other digestive diseases and the rising preference for minimally invasive procedures are some...Read More >>>

Published:
2017-12-07

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

Oncology Drugs market covers drugs that are used in the treatment of a wide range of cancer, sarcoma, and tumor. Some of the bestselling oncology drugs in 2016 include Avastin, Herceptin, Revlimid, MabThera/Rituxan, Gleevac/Glivec, Alimta, Zytiga, Tasigna, Sandostatin, and Afinitor.


The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$3400

save $600 today

Patient Positioning System Market by Product (Tables (Surgical Tables, Radiolucent Imaging Tables), Accessories), Application (Surgery, Cancer Therapy, Disease Diagnosis), and End User (Hospitals, Ambulatory Surgery Center) - Global Forecast to 2022 [Report Updated: 06-06-2017]

The patient positioning systems market was valued at USD 990 million in 2017 and expected to grow at a CAGR of 4.5% to a USD 1,233.8 million market by 2022. Factors driving this market are increasing incidence of accidents, growing hospital investments, prevalence of non-communicable diseases, and technological advancements in the field of patient positioning. On the other hand, availability of re...Read More >>>

Published:
2017-06-06

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$4565

save $806 today

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma an [Report Updated: 24-04-2017]

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for 6 billion in 2015, and is anticipated to reach 9 billion by 2022, registering a CAGR of 6.8% from 2016 to 2022.nnOrphan drugs are used to treat rare (orphaned) diseases prevalent in a very small patie...Read More >>>

Published:
2017-04-24

Published by: Allied Market Research

Prices Starting From:
$4565

save $806 today

Published:
2017-01-18

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$4565

save $806 today

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021 [Published by MarketsandMarkets]

The vaccine adjuvants market is expected to reach USD 769.4 million by 2021 from USD 467.0 million in 2016, at a CAGR of 10.5%. The global vaccine adjuvants market is segmented based on product type, route of administration, disease type, applications, and application categories. On the basis of type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particula...Read More >>>

Published:
2016-06-15

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Published:
2015-12-02

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020 [Published by MarketsandMarkets]

The NGS services market in Europe is expected to reach USD 1,152 million by 2020 from USD 444 million in 2015, at a CAGR of 21% from 2015 to 2020. The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country. The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference o...Read More >>>

Published:
2015-10-13

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020 [Published by MarketsandMarkets]

According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polym...Read More >>>

Published:
2015-06-10

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019 [Published by MarketsandMarkets]

The vaccines market is expected to reach ,885.4 million by 2019 from ,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growt...Read More >>>

Published:
2015-01-26

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Patient Registry Software Market by Delivery Mode (Subscription, Ownership), Functionality (Population Health Management, Point of Care, Care Management), Database (Diabetes, Cancer, Cardiovascular, Chronic & Rare Disease) & by End User - Forecast to 2019 [Published by MarketsandMarkets]

The patient registry software market is expected to reach 0.8 million by 2019 from 1.0 million in 2014, at a CAGR of 9.9%. The global patient registry software market is categorized on the basis of delivery model, product type, database type, functionality, end user, and region. The subscription models segment is expected to register the highest growth rate in the patient registry software m...Read More >>>

Published:
2015-01-09

Published by: MarketsandMarkets

Prices Starting From:
$4803

save $848 today

Additional Searches

You may also like to search separately for: Cancer Disease

We Stock...